Inhibrx Biosciences Inc's total assets for Q4 2024 were $180.77M, a decrease of -18.78% from the previous quarter. INBX total liabilities were $47.18M for the fiscal quarter, a 7.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.